Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
22.5M
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
233K
-
Shares change
-
+233K
-
Total reported value, excl. options
-
$320K
-
Value change
-
+$319K
-
Put/Call ratio
-
0
-
Number of buys
-
14
-
Price
-
$1.37
Significant Holders of iBio, Inc. - Common Stock, $0.001 par value per share (IBIO) as of Q4 2023
19 filings reported holding IBIO - iBio, Inc. - Common Stock, $0.001 par value per share as of Q4 2023.
iBio, Inc. - Common Stock, $0.001 par value per share (IBIO) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 233K shares
of 22.5M outstanding shares and own 1.04% of the company stock.
Largest 10 shareholders include SABBY MANAGEMENT, LLC (177K shares), CITADEL ADVISORS LLC (25.4K shares), Warberg Asset Management LLC (19K shares), BlackRock Inc. (6.89K shares), Tower Research Capital LLC (TRC) (4.78K shares), MORGAN STANLEY (339 shares), OSAIC HOLDINGS, INC. (58 shares), GROUP ONE TRADING, L.P. (50 shares), CITIGROUP INC (42 shares), and HARBOUR INVESTMENTS, INC. (40 shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.